Abstract:Atherosclerosis and resulting cardiovascular disease are the leading causes of death in the US. Hyperhomocysteinemia (HHcy), or the accumulation of the intermediate amino acid homocysteine, is an independent risk factor for atherosclerosis, but the intricate biological processes mediating this effect remain elusive. Several factors regulate homocysteine levels, including the activity of several enzymes and adequate levels of their coenzymes, including pyridoxal phosphate (vitamin B6), folate (vitamin B9), and methylcobalamin (vitamin B12). To better understand the biological influence of HHcy on the development and progression of atherosclerosis, apolipoprotein-E-deficient (apoE−/− mice), a model for human atherosclerosis, were fed a hyperhomocysteinemic diet (low in methyl donors and B vitamins) (HHD) or a control diet (CD). After eight weeks, the plasma, aorta, and liver were collected to quantify methylation metabolites, while plasma was also used for a broad targeted metabolomic analysis. Aortic plaque burden in the brachiocephalic artery (BCA) was quantified via 14T magnetic resonance imaging (MRI). A severe accumulation of plasma and hepatic homocysteine and an increased BCA plaque burden were observed, thus confirming the atherogenic effect of the HHD. Moreover, a decreased methylation capacity in the plasma and aorta, indirectly assessed by the ratio of S-adenosylmethionine to S-adenosylhomocysteine (SAM:SAH) was detected in HHD mice together with a 172-fold increase in aortic cystathionine levels, indicating increased flux through the transsulfuration pathway. Betaine and its metabolic precursor, choline, were significantly decreased in the livers of HHD mice versus CD mice. Widespread changes in the plasma metabolome of HHD mice versus CD animals were detected, including alterations in acylcarnitines, amino acids, bile acids, ceramides, sphingomyelins, triacylglycerol levels, and several indicators of dysfunctional lipid metabolism. This study confirms the relevance of severe HHcy in the progression of vascular plaque and suggests novel metabolic pathways implicated in the pathophysiology of atherosclerosis.

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Number and Activity of Endothelial Progenitor Cells from Peripheral Blood in Patients with Hypercholesterolaemia

Corrigendum to “Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood” [J. Mol. Cell. Cardiol. 36 (2004) 233–239]

Effect of Homocysteine on Expression of Intercellular Adhesion Molecule-2 and Adhesion of Dendritic Cells to Cultured Human Umbilical Vein Endothelial Cells

Endothelial progenitor cells are associated with plasma homocysteine in coronary artery disease.

[Changes of endothelial progenitor cells from peripheral blood in patients with coronary heart diseases].

Clinical Significance of Plasma Homocysteine in the Coronary Atherosclerosis Patients

Adiponectin Levels Are Associated with the Number and Activity of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease

Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.

Homocysteine Impairs Coronary Artery Endothelial Function by Uncoupling Endothelial Nitric Oxide Synthase in Patients with Hyperhomocysteinemia

Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)

Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules

Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells

Hyperhomocysteinemia and Hyperlipidemia in Coronary Heart Disease.

Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia

Homocysteine Causes Vascular Endothelial Dysfunction by Disrupting Endoplasmic Reticulum Redox Homeostasis.

Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice

Changes in Number and Function of Bone Marrow-Derived EPCs in Atherosclerotic Rats

Homocysteine Enhances Neutrophil-Endothelial Interactions in Both Cultured Human Cells and Rats In Vivo